Fresenius SE & Co. KGaA (FSNUF)
USD 37.73
(-5.68%)
USD 37.73
(-5.68%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 25.63 Billion EUR | -42.0% |
| 2022 | 44.19 Billion EUR | 3.57% |
| 2021 | 42.67 Billion EUR | 5.05% |
| 2020 | 40.62 Billion EUR | 0.49% |
| 2019 | 40.42 Billion EUR | 27.55% |
| 2018 | 31.69 Billion EUR | 0.9% |
| 2017 | 31.41 Billion EUR | 26.45% |
| 2016 | 24.84 Billion EUR | 2.57% |
| 2015 | 24.22 Billion EUR | 2.05% |
| 2014 | 23.73 Billion EUR | 24.74% |
| 2013 | 19.02 Billion EUR | 8.67% |
| 2012 | 17.5 Billion EUR | 11.2% |
| 2011 | 15.74 Billion EUR | 6.86% |
| 2010 | 14.73 Billion EUR | 11.36% |
| 2009 | 13.23 Billion EUR | -2.73% |
| 2008 | 13.6 Billion EUR | 1024.98% |
| 2007 | 1.2 Billion EUR | 2.11% |
| 2006 | 1.18 Billion EUR | 31.7% |
| 2005 | 899 Million EUR | 69.3% |
| 2004 | 531 Million EUR | -89.66% |
| 2003 | 5.13 Billion EUR | -7.45% |
| 2002 | 5.54 Billion EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 24.16 Billion EUR | -5.72% |
| 2024 Q2 | 23.91 Billion EUR | -1.06% |
| 2023 FY | 25.63 Billion EUR | -42.0% |
| 2023 Q3 | 45.04 Billion EUR | 0.14% |
| 2023 Q4 | 25.63 Billion EUR | -43.1% |
| 2023 Q2 | 44.98 Billion EUR | 1.36% |
| 2023 Q1 | 44.38 Billion EUR | 0.41% |
| 2022 Q2 | 44.07 Billion EUR | 3.64% |
| 2022 Q4 | 44.19 Billion EUR | -4.28% |
| 2022 FY | 44.19 Billion EUR | 3.57% |
| 2022 Q1 | 42.53 Billion EUR | -0.34% |
| 2022 Q3 | 46.17 Billion EUR | 4.75% |
| 2021 Q4 | 42.67 Billion EUR | -0.52% |
| 2021 Q2 | 42.52 Billion EUR | 2.59% |
| 2021 Q3 | 42.89 Billion EUR | 0.87% |
| 2021 FY | 42.67 Billion EUR | 5.05% |
| 2021 Q1 | 41.45 Billion EUR | 2.04% |
| 2020 Q3 | 42.12 Billion EUR | -0.43% |
| 2020 Q1 | 42.01 Billion EUR | 3.93% |
| 2020 FY | 40.62 Billion EUR | 0.49% |
| 2020 Q2 | 42.3 Billion EUR | 0.68% |
| 2020 Q4 | 40.62 Billion EUR | -3.55% |
| 2019 Q1 | 39.15 Billion EUR | 23.54% |
| 2019 FY | 40.42 Billion EUR | 27.55% |
| 2019 Q4 | 40.42 Billion EUR | 0.91% |
| 2019 Q3 | 40.06 Billion EUR | 1.3% |
| 2019 Q2 | 39.54 Billion EUR | 1.0% |
| 2018 Q1 | 31.48 Billion EUR | 0.22% |
| 2018 FY | 31.69 Billion EUR | 0.9% |
| 2018 Q4 | 31.69 Billion EUR | -0.09% |
| 2018 Q3 | 31.72 Billion EUR | 0.04% |
| 2018 Q2 | 31.71 Billion EUR | 0.73% |
| 2017 Q1 | 32.49 Billion EUR | 30.81% |
| 2017 FY | 31.41 Billion EUR | 26.45% |
| 2017 Q2 | 31.87 Billion EUR | -1.91% |
| 2017 Q4 | 31.41 Billion EUR | -1.62% |
| 2017 Q3 | 31.93 Billion EUR | 0.17% |
| 2016 Q2 | 24.25 Billion EUR | 3.32% |
| 2016 Q1 | 23.47 Billion EUR | -3.06% |
| 2016 Q4 | 24.84 Billion EUR | 3.98% |
| 2016 Q3 | 23.89 Billion EUR | -1.51% |
| 2016 FY | 24.84 Billion EUR | 2.57% |
| 2015 Q1 | 24.99 Billion EUR | 5.3% |
| 2015 Q4 | 24.22 Billion EUR | 0.33% |
| 2015 Q3 | 24.14 Billion EUR | -1.83% |
| 2015 Q2 | 24.59 Billion EUR | -1.6% |
| 2015 FY | 24.22 Billion EUR | 2.05% |
| 2014 Q1 | 20.2 Billion EUR | 6.2% |
| 2014 FY | 23.73 Billion EUR | 24.74% |
| 2014 Q4 | 23.73 Billion EUR | 6.68% |
| 2014 Q3 | 22.24 Billion EUR | 4.44% |
| 2014 Q2 | 21.3 Billion EUR | 5.43% |
| 2013 FY | 19.02 Billion EUR | 8.67% |
| 2013 Q1 | 17.58 Billion EUR | 0.42% |
| 2013 Q2 | 17.6 Billion EUR | 0.12% |
| 2013 Q3 | 17.29 Billion EUR | -1.72% |
| 2013 Q4 | 19.02 Billion EUR | 9.98% |
| 2012 FY | 17.5 Billion EUR | 11.2% |
| 2012 Q3 | 17.69 Billion EUR | -4.54% |
| 2012 Q2 | 18.53 Billion EUR | 4.64% |
| 2012 Q1 | 17.71 Billion EUR | 12.51% |
| 2012 Q4 | 17.5 Billion EUR | -1.05% |
| 2011 Q1 | 14.78 Billion EUR | 0.35% |
| 2011 Q2 | 15.2 Billion EUR | 2.85% |
| 2011 Q3 | 14.65 Billion EUR | -3.6% |
| 2011 Q4 | 15.74 Billion EUR | 7.41% |
| 2011 FY | 15.74 Billion EUR | 6.86% |
| 2010 Q3 | 14.21 Billion EUR | -6.93% |
| 2010 Q4 | 14.73 Billion EUR | 3.66% |
| 2010 FY | 14.73 Billion EUR | 11.36% |
| 2010 Q2 | 15.27 Billion EUR | 10.14% |
| 2010 Q1 | 13.86 Billion EUR | 4.81% |
| 2009 FY | 13.23 Billion EUR | -2.73% |
| 2009 Q4 | 13.23 Billion EUR | 0.0% |
| 2008 FY | 13.6 Billion EUR | 1024.98% |
| 2007 FY | 1.2 Billion EUR | 2.11% |
| 2006 FY | 1.18 Billion EUR | 31.7% |
| 2005 FY | 899 Million EUR | 69.3% |
| 2004 FY | 531 Million EUR | -89.66% |
| 2003 FY | 5.13 Billion EUR | -7.45% |
| 2002 FY | 5.54 Billion EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | -103636.82% |
| Arem Pacific Corporation | 304.9 Thousand USD | -8406835.976% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -13918245.849% |
| BioCorRx Inc. | 10.34 Million USD | -247767.53% |
| Bionik Laboratories Corp. | 5 Million USD | -512281.777% |
| Banyan Corp. | 4.51 Million USD | -567198.316% |
| Clearday, Inc. | 65.13 Million USD | -39255.407% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -1422295.304% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -1704299044.958% |
| Empower Clinics Inc. | 9.18 Million USD | -278952.096% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | -80880.539% |
| Selectis Health, Inc. | 43.63 Million USD | -58643.791% |
| Ethema Health Corporation | 17.71 Million USD | -144560.197% |
| HealthLynked Corp. | 3.47 Million USD | -737453.267% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | -176987.675% |
| JRSIS Health Care Corporation | 2.3 Million USD | -1111875.349% |
| Comjoyful International Company | 6.32 Million USD | -405094.674% |
| Medical Facilities Corporation | 235.37 Million USD | -10790.44% |
| MedSmart Group Inc. | 927.53 Thousand USD | -2763473.401% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -2735983.685% |
| Nova Leap Health Corp. | 2.69 Million USD | -949637.602% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -889276.028% |
| PAO Group, Inc. | 1.04 Million USD | -2449157.665% |
| Primemd Inc. | 7.98 Million USD | -320766.004% |
| Raffles Medical Group Ltd | 367.04 Million USD | -6883.563% |
| Ryman Healthcare Limited | 5.17 Billion USD | -394.85% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -31832250.202% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -654501.247% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -603352.72% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -3791763.905% |
| Veltex Corporation | 2.87 Million USD | -890789.11% |
| World Financial Holding Group | 132.5 Thousand USD | -19344830.38% |
| Xcelerate Inc. | 2.07 Million USD | -1234886.052% |